Compare FEIM & MLAB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | FEIM | MLAB |
|---|---|---|
| Founded | 1961 | 1982 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Electrical Products | Industrial Machinery/Components |
| Sector | Industrials | Industrials |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 494.3M | 489.8M |
| IPO Year | 1994 | 1995 |
| Metric | FEIM | MLAB |
|---|---|---|
| Price | $47.66 | $78.40 |
| Analyst Decision | Buy | Hold |
| Analyst Count | 2 | 1 |
| Target Price | $42.50 | ★ $94.00 |
| AVG Volume (30 Days) | ★ 149.6K | 103.3K |
| Earning Date | 06-15-2026 | 05-04-2026 |
| Dividend Yield | N/A | ★ 0.82% |
| EPS Growth | ★ 316.95 | 99.24 |
| EPS | 0.25 | ★ 1.95 |
| Revenue | ★ $69,811,000.00 | N/A |
| Revenue This Year | $5.52 | $6.07 |
| Revenue Next Year | $17.07 | $5.41 |
| P/E Ratio | $186.64 | ★ $39.90 |
| Revenue Growth | ★ 26.30 | N/A |
| 52 Week Low | $14.41 | $59.63 |
| 52 Week High | $61.47 | $130.12 |
| Indicator | FEIM | MLAB |
|---|---|---|
| Relative Strength Index (RSI) | 44.96 | 36.39 |
| Support Level | $45.65 | $77.23 |
| Resistance Level | $59.91 | $81.62 |
| Average True Range (ATR) | 4.94 | 4.13 |
| MACD | -0.28 | -2.06 |
| Stochastic Oscillator | 23.55 | 27.83 |
Frequency Electronics Inc is engaged in the design, development, and manufacture of high-precision timing, and frequency control products for space, air, sea, and terrestrial applications. The company has FEI-NY and FEI-Zyfer reportable segments. It derives the majority of its revenues from the FEI-NY segment. FEI-NY segment operations consist principally of precision time and frequency control products used in three principal markets namely communication satellites (both commercial and U.S. Government-funded); terrestrial cellular telephone or other ground-based telecommunication stations; and other components and systems for the U.S. military.
Mesa Laboratories Inc manufactures life sciences tools and critical quality control products. It operates in four divisions: Sterilization and Disinfection Control, which manufactures and sells biological, chemical, and cleaning indicators used to assess the effectiveness of sterilization, decontamination, disinfection, and cleaning processes. Clinical Genomics division develops, manufactures, and sells highly sensitive, low-cost, high-throughput genetic analysis tools and related consumables. The Biopharmaceutical Development division develops, manufactures, and sells automated systems for protein analysis (immunoassays) and peptide synthesis solutions. The Calibration Solutions division develops, manufactures, sells, and services quality control products.